Wokolorczyk, D., Gliniewicz, B., Sikorski, A., Zlowocka, E., Masojc, B., Defniak, T., Matyjasik, J., Miergejewski, M., Medrek, K., Oszutowska, D., Suchy, J., Gronwald, J., Teodrczyk, U., Juzarski, T., Byrski, T., Jakuborwska, A., Gorski, B., Van de Wetering, T., Walczak, S., Nurod, S.A., Lubrinski, J. and Cybulski, C. (2008) A Range of Cancers Is Associated with the rs 6983267 Marker on Chromosome 8. Cancer Research, 68, 9982-9986. http://dx.doi.org/10.1158/0008-5472.CAN-08-1838

has been cited by the following article:

• TITLE: Want to Cure Cancer? Then Revisit the Past; “Warburg Was Correct”, Cancer Is a Metabolic Disease

  AUTHORS: Robert L. Elliott, Xian P. Jiang, Jonathan F. Head

  KEYWORDS: Host Immunity; Mitochondrial Dysfunction; Warburg Effect; Aerobic Fermentation; Tumor and Mitochondrial Iron Metabolism

  JOURNAL NAME: Journal of Cancer Therapy, Vol.5 No.3, March 25, 2014

  ABSTRACT: I want to make it very clear at the beginning of this communication; this is a controversial opinion review. However, I believe it is time to rethink our approach to cancer research and therapy. Many cancer researchers, especially those involved in cancer genomic research will disagree. I welcome the disagreement and hope it will stimulate an honest debate and dialog between all disciplines of cancer research and treatment. I am convinced that a vast disconnection exists between those involved in basic research and those in the clinical arena that treat this disease. Cancer researchers in all areas should not ignore the role of cancer metabolism in tumorigenesis, progression and metastasis.